Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$TEVA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.49 down -296.00% YoY • Reported revenue of $4.14B down -0.81% YoY • Teva Pharmaceutical Industries Ltd. expects 2026 revenue of $16.5-$16.85 billion, non-GAAP operating income of $3.8-$4.0 billion, and non-GAAP diluted EPS of $1.91-$2.11, while maintaining its free cash flow outlook.
1

Price since post

Full Details

Advertisement|Remove ads.